Results 141 to 150 of about 6,477 (199)

CAR-based cell therapy for autoimmune diseases. [PDF]

Front Immunol
Li X, He C, Wang K, Xu GY, Xie YC, Ying XY.   +5 more
europepmc   +1 more source

Engineering Immunity: Current Progress and Future Directions of CAR-T Cell Therapy. [PDF]

Int J Mol Sci
Sioud M, Casey NP.
europepmc   +1 more source

Research progress on chimeric antigen receptor-based immunotherapy against autoimmune diseases. [PDF]

Hum Vaccin Immunother
Jiang M, Zhao J, Yuan J, Yu Z, Liu J, Zhu Z, Ning X, Sun S.   +7 more
europepmc   +1 more source

Author response: Calcium-mediated actin reset (CaAR) mediates acute cell adaptations

, 2016
Roland Aufschnaiter, Christian E Schuberth, Pauline Wales, Johannes Fels, Ireth García-Aguilar, Annette Janning, Christopher P Dlugos, Marco Schäfer-Herte, Christoph Klingner, Mike Wälte, Julian Kuhlmann, Ekaterina Menis, Laura Hockaday Kang, Kerstin C Maier, Wenya Hou, Antonella Russo, Henry N Higgs, Hermann Pavenstädt, Thomas Vogl, Johannes Roth, Britta Qualmann, Michael M Kessels, Dietmar E Martin, Bela Mulder, Roland Wedlich-Söldner   +24 more
openaire   +1 more source

Current advancements in cellular immunotherapy for autoimmune disease. [PDF]

Semin Immunopathol
Berry CT, Frazee CS, Herman PJ, Chen S, Chen A, Kuo Y, Ellebrecht CT.   +6 more
europepmc   +1 more source

How does the Vietnamese stock market react when the Fed gives an announcement in time at the zero lower bound? [PDF]

Heliyon
Ngo N, Nguyen H, Nguyen Y, Le S.
europepmc   +1 more source

CAR T-cells meet autoimmune neurological diseases: a new dawn for therapy. [PDF]

Front Immunol
Chinas NA, Alexopoulos H.
europepmc   +1 more source

Advances in B Cell Targeting for Treating Muscle-Specific Tyrosine Kinase-Associated Myasthenia Gravis. [PDF]

Immunotargets Ther
Hu G, Zhao X, Wang Y, Zhu X, Sun Z, Yu X, Wang J, Liu Q, Zhang J, Zhang Y, Yang J, Chang T, Ruan Z, Lv J, Gao F.   +14 more
europepmc   +1 more source

CAR-engineered T cell therapy as an emerging strategy for treating autoimmune diseases. [PDF]

Front Med (Lausanne)
Vukovic J, Abazovic D, Vucetic D, Medenica S.   +3 more
europepmc   +1 more source

Immunological Targets in Generalized Myasthenia Gravis Treatment: Where Are We Going Now? [PDF]

Brain Sci
Rossini E, Leonardi L, Morino S, Antonini G, Fionda L.   +4 more
europepmc   +1 more source